CD44 and non-small cell lung carcinoma: However, a study from China showed that CD44 rs187115 polymorphism was associated with a decreased risk for non-small cell lung cancer (NSCLC), but was also significantly related with bone metastasis and tumor stage for NSCLC patients [21].